A detailed history of Larson Financial Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Larson Financial Group LLC holds 15,461 shares of BMY stock, worth $886,379. This represents 0.05% of its overall portfolio holdings.

Number of Shares
15,461
Previous 8,771 76.27%
Holding current value
$886,379
Previous $364,000 119.78%
% of portfolio
0.05%
Previous 0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $265,325 - $346,207
6,690 Added 76.27%
15,461 $800,000
Q2 2024

Aug 02, 2024

BUY
$40.25 - $52.99 $195,776 - $257,743
4,864 Added 124.49%
8,771 $364,000
Q1 2024

May 03, 2024

SELL
$47.98 - $54.4 $9,691 - $10,988
-202 Reduced 4.92%
3,907 $211,000
Q4 2023

Feb 01, 2024

SELL
$48.48 - $57.85 $9,259 - $11,049
-191 Reduced 4.44%
4,109 $210,000
Q3 2023

Nov 03, 2023

BUY
$57.89 - $64.73 $19,277 - $21,555
333 Added 8.39%
4,300 $249,000
Q2 2023

Aug 03, 2023

SELL
$63.71 - $70.74 $1.59 Million - $1.76 Million
-24,927 Reduced 86.27%
3,967 $253,000
Q1 2023

May 04, 2023

BUY
$65.71 - $74.53 $20,041 - $22,731
305 Added 1.07%
28,894 $2 Million
Q4 2022

Feb 03, 2023

BUY
$68.48 - $81.09 $237,831 - $281,625
3,473 Added 13.83%
28,589 $2.06 Million
Q3 2022

Nov 03, 2022

BUY
$0.13 - $76.84 $2,801 - $1.66 Million
21,552 Added 604.71%
25,116 $1.79 Million
Q2 2022

Aug 04, 2022

BUY
$72.62 - $79.98 $28,539 - $31,432
393 Added 12.39%
3,564 $274,000
Q1 2022

May 05, 2022

SELL
$61.48 - $73.72 $80,784 - $96,868
-1,314 Reduced 29.3%
3,171 $232,000
Q4 2021

Feb 03, 2022

BUY
$53.63 - $62.52 $71,542 - $83,401
1,334 Added 42.34%
4,485 $280,000
Q3 2021

Nov 04, 2021

SELL
$59.17 - $69.31 $17,218 - $20,169
-291 Reduced 8.45%
3,151 $186,000
Q2 2021

Aug 10, 2021

BUY
$61.91 - $67.42 $19,130 - $20,832
309 Added 9.86%
3,442 $230,000
Q1 2021

May 06, 2021

SELL
$59.34 - $66.74 $9,316 - $10,478
-157 Reduced 4.77%
3,133 $198,000
Q4 2020

Jan 14, 2021

SELL
$57.74 - $65.43 $36,029 - $40,828
-624 Reduced 15.94%
3,290 $204,000
Q3 2020

Oct 08, 2020

BUY
$57.43 - $63.64 $574 - $636
10 Added 0.26%
3,914 $236,000
Q2 2020

Jul 10, 2020

BUY
$54.82 - $64.09 $13,979 - $16,342
255 Added 6.99%
3,904 $230,000
Q1 2020

Apr 09, 2020

BUY
$46.4 - $67.43 $17,910 - $26,027
386 Added 11.83%
3,649 $203,000
Q4 2019

Jan 10, 2020

BUY
$49.21 - $64.19 $12,893 - $16,817
262 Added 8.73%
3,263 $209,000
Q3 2019

Oct 11, 2019

BUY
$42.77 - $50.71 $54,275 - $64,350
1,269 Added 73.27%
3,001 $152,000
Q2 2019

Jul 16, 2019

BUY
$44.62 - $49.34 $22,310 - $24,670
500 Added 40.58%
1,732 $79,000
Q4 2018

Feb 07, 2019

BUY
$48.76 - $63.23 $60,072 - $77,899
1,232 New
1,232 $64,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Larson Financial Group LLC Portfolio

Follow Larson Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.